Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC
Authors:
Open Access
- 30 September 2016
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 31 (5) , e22075
Abstract
Background Inflammation plays an important role in the development and progression of CRC. The members of inflammatory biomarkers, preoperative NLR and PLR, have been proved by numerous studies to be promising prognostic biomarkers for CRC. However, the diagnostic value of the two biomarkers in CRC remains unknown, and no study reported the combined diagnostic efficacy of NLR, PLR and CEA. Methods Five hundred and fifty‐nine patients with I‐III stage CRC undergoing surgical resection and 559 gender‐ and age‐matched healthy controls were enrolled in this retrospective study. NLR and PLR were calculated from preoperative peripheral blood cell count detected using white blood cell five classification by Sysmex XT‐1800i Automated Hematology System and serum CEA were measured by electrochemiluminescence by ELECSYS 2010. The diagnostic performance of NLR, PLR and CEA for CRC was evaluated by ROC curve. Results Levels of NLR and PLR in the cases were significantly higher than them in the healthy controls. ROC curves comparison analyses showed that the diagnostic efficacy of NLR (AUC=.755, 95%CI=.728‐.780) alone for CRC was significantly higher than PLR (AUC=.723, 95%CI=.696‐.749, P=.037) and CEA (AUC=.690, 95%CI=.662‐.717, P=.002) alone. In addition, the diagnostic efficacy of the combination of NLR, PLR and CEA(AUC=.831, 95%CI=.807‐.852)for CRC was not only significantly higher than NLR alone but also higher than any combinations of the two of these three biomarkers (P<.05). Moreover, the NLR and PLR in the patients with TNM stage I/II was higher than that in the healthy controls, and patients with stage III had a higher NLR and PLR than those with stage I/II, but no significant difference was observed. Conclusion Our study indicated that preoperative NLR could be a CRC diagnostic biomarker, even for early stage CRC, and the combination of NLR, PLR and CEA could significantly improve the diagnostic efficacy.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities
- University Graduate Student Scientific Innovation Project of Jiangsu (SJZZ15_0027)
- National Natural Science Foundation of China (81472027)
This publication has 35 references indexed in Scilit:
- Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer?Cancer Treatment Reviews, 2013
- Tumor-associated neutrophils: friend or foe?Carcinogenesis, 2012
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis, 2009
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian CancersClinical Chemistry, 2008
- Cancer-related inflammationNature, 2008
- Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumoniaBMC Infectious Diseases, 2007
- Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancerInternational Journal of Colorectal Disease, 2007
- Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Platelets and Granulocytes, in Particular the Neutrophils, Form Important Compartments for Circulating Vascular Endothelial Growth FactorAngiogenesis, 2003
- Inflammation and cancerNature, 2002